Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3838 San Dimas St
Ste A200
Bakersfield, CA 93301
Summary
- Dr. Shah is American Board Certified in Endocrinology, Diabetes & Metabolism (ABMS), Clinical Densitometry (ISCD), Obesity Medicine (ABOM) and Internal Medicine (ABIM). He completed the certificate program in Plant Based Nutrition through eCornell.
Dr. Shah graduated from Sardar Patel University in India. He completed his Residency at Loma Linda University, CA and his Fellowship at University of Florida- Jacksonville. He served as a Quality Improvement Chief Resident at VA Hospital.
He has contributed to a wide range of publications and participated in many research projects. He has presented multiple abstracts at various regional and national meetings. His monograph for Thyroid Function testing was published in BMJ Point of Care.
Dr. Shah has been awarded the Fellowship of the American College of Endocrinology (FACE), Fellowship of The American College of Physicians (FACP), "2017 -America's Top Physicians" by The Consumers Research Council of America and "2018- Top Endocrinologist in California" by Top Doctor Awards.
He is an active member of The American Association of Clinical Endocrinologists, The Endocrine Society & The American Thyroid Association.
He manages Diabetes, Thyroid, Adrenal, Pituitary, Lipids, Bone, Calcium and Reproductive disorders. His Clinical areas of interests are Thyroid Cancer, Endocrine Hypertension, Plant Based Nutrition and Diabetes Technologies (Insulin pumps and Continuous Glucose Monitors).
Clinical Expertise
- Hirsutism, Thyroid disorders, Obesity and obesity-related disorders, Lipid metabolism disorders, Osteoporosis, Calcium and bone metabolism, Parathyroid disorders, Hyperparathyroidism, Galactorrhea, Diabetes, Thryoid nodules, Thyroid cancer, Diabetes mellitus type 1, Diabetes mellitus type 2, Hypoglycemia, Insulin pump management, Low testosterone, Pituitary disease, Parathyroid disease, Adrenal disease, Continuous glucose monitoring, Endocrine hypertension, Menstrual irregularities, Plant based nutrition
Education & Training
- University of Florida College of Medicine JacksonvilleFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2015
- Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 2009 - 2012
- Pramukhswami Medical CollegeClass of 2007
Certifications & Licensure
- CA State Medical License 2011 - 2026
- FL State Medical License 2015 - 2017
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
- eCornellPlant Based Nutrition
- International Society of Clinical DensitometryCertified Clinical Densitometrist
Awards, Honors, & Recognition
- FACE American Association of Clinical Endocrinologists, 2019
- Top Endocrinologist Top Doctor Awards, 2018
- FACP American College Of Physicians, 2017
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsBeta Blockers Suppress Dextrose-Induced Endoplasmic Reticulum Stress, Oxidative Stress, and Apoptosis in Human Coronary Artery Endothelial Cells.Michael J. Haas, William Kurban, Harshit Shah, Luisa Onstead-Haas, Arshag D. Mooradian
American Journal of Therapeutics. 2016-11-01 - 4 citationsHigh-Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-I SynthesisMichael J. Haas, Luisa Onstead-Haas, William Kurban, Harshit Shah, Monica Plazarte
Assay and Drug Development Technologies. 2017-12-01
Journal Articles
- Beta Blockers Suppress Dextrose-Induced Endoplasmic Reticulum Stress, Oxidative Stress and Apoptosis in Human Coronary Artery Endothelial CellsMichael J. Haas, Ph. D., Harshit Shah, M.D., William Kurban, M.D., Luisa Onstead-Haas, M.S. Arshag D. Mooradian, M.D., American Journal of Therapeutics
- High - Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-1 SynthesisHaas Michael J., Onstead-Haas Luisa, Kurban William, Harshit Shah, Monica Plazarte, ASSAY and Drug Development Technologies, 1/1/2017
- Statin Induced Rhabdomyolysis - Retrospective study on VA Patient populationHarshit Shah MD, John Jennings MD, Journal of Clinical Endocrinology and Metabolism, 1/1/2012
Books/Book Chapters
Abstracts/Posters
- Statin Induced Rhabdomyolysis - Retrospective Study on VA Patient populationShah H, Endocrine Society, 2012
- Beta Blockers suppress Dextrose-Induced Endoplasmic Reticulum stress, oxidative stress and Apoptosis in Human coronary artery Endothelial cellsShah H, AACE, 2015
- - Inhibition of ABCA1 protein expression and cholesterol efflux by TNF-alpha in MLO-Y4 Osteocytes, AACE-2015Monica Plazarte, DO, Kent wehmeier, MD, Salma Makhoul Ahwach, MD, Melanie Thomas, MD, William Kurban, MD, Harshit Shah, MD, Ayham Chamseddin, MD, Mae SheikhAli, MD, Lu..., AACE, 2015
- Join now to see all
Lectures
- Diabetes and DementiaUniversity of Florida, Jacksonville, FL - 1/1/2015
- Non-Invasive techniques for localization of Aldosterone Producing AdenomaUniversity of Florida, Jacksonville, FL - 1/1/2015
- Approach to patient with a negative scan and positive Thyroglobulin after initial therapy of Differentiated Thyroid CancerUniversity of Florida, Jacksonville, FL - 1/1/2014
- Join now to see all
Authored Content
- Weight Gain Related to HypothyroidismMay 2019
- Managing Diabetes in the Heat7/23/2018
Research History
- A phase II, 16 week, double-blinded, Placebo-controlled, Parallel- group, randomized, multicenter trial to assess effect on glycemic control of three dosage of HM11260C in subjects with inadequately cSub Investigator- Harshit Shah, M.D. Principal Investigator- Mae Sheikh-Ali, M.D. HM-EXC-2042014 - 2016
- A randomized, double blinded, cross-over trail comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 DiabetesSub Investigator- Harshit Shah, M.D. Principal Investigator- Mae Sheikh-Ali, M.D. NN1250- 39952014 - 2016
- Efficacy and Safety of Switching from Sitagliptin to Liraglutide in Subjects with type 2 Diabetes not Achieving Adequate Glycemic Control on Sitagliptin and Metformin.Sub Investigator- Harshit Shah, M.D. Principal Investigator- Mae Sheikh-Ali, M.D. NN2211-40592014 - 2016
- Nodular Characteristics of Papillary and Follicular Thyroid cancer on Thyroid ultrasound. Is there a difference?M.Thomas MD, P.Pirgousis MD, M.Gladysz MD, H.Shah MD, M.Sheikh- Ali MD2014 - 2016
- Diabetics who are not on ACEI/ARB and statin even when indicatedQuality Improvement Project2013 - 2015
- Starting subcutaneous Insulin before stopping IV Insulin Drip in DKA patients- Inpatient studyQuality Improvement Project2013 - 2015
- Statin Induced Rhabdomyolysis- Retrospective study on VA patient PopulationHarshit Shah MD John Jennings MD2011 - 2012
Professional Memberships
- Fellow
- Fellow
- Member
- Member
Other Languages
- Hindi
External Links
- LinkedInhttp://www.linkedin.com/in/harshitshahmd
- Healthgradeshttps://www.healthgrades.com/physician/dr-harshit-shah-gcfwv
- DHMFhttps://www.dignityhealth.org/ourdoctors/1043453079-Harshit-Shah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: